ETFOptimize | High-performance ETF-based Investment Strategies

Quantitative strategies, Wall Street-caliber research, and insightful market analysis since 1998.


ETFOptimize | HOME
Close Window

26 Patient Volunteer Leaders Attend the Foundation for Sarcoidosis Research Global Sarcoidosis Clinic Alliance Volunteer Patient Leadership Advanced Training Conference held at Cleveland Clinic

CHICAGO, March 27, 2024 (GLOBE NEWSWIRE) -- 26 Patient Volunteer Leaders representing 16 states and 17 hospitals joined the Foundation for Sarcoidosis Research (FSR) at the inaugural FSR Global Sarcoidosis Clinic Alliance (FSR-GSCA) Volunteer Patient Leadership Advanced Training Conference held at Cleveland Clinic. This groundbreaking event, which took place from March 8th to March 10th, 2024, brought together passionate Volunteer Leaders from across the nation dedicated to advancing awareness, support, and research for sarcoidosis.

The FSR-GSCA Volunteer Patient Leadership Advanced Training Conference marked a pivotal moment in the fight against sarcoidosis, a rare disease characterized by the growth of inflammatory cells in various organs of the body. Hosted at Cleveland Clinic, renowned for its expertise in medical research and patient care, the conference and private tour of Cleveland Clinic’s sarcoidosis clinic provided an invaluable platform for patients, caregivers, healthcare professionals, and researchers to collaborate and drive progress in the field.

Throughout the three-day event, attendees participated in a comprehensive program featuring educational sessions, workshops, and interactive discussions led by leading experts in sarcoidosis research and advocacy. From understanding the latest advancements in treatment options, to learning effective advocacy and story-telling strategies, participants gained invaluable knowledge and skills to make a meaningful impact within their communities.

"We are immensely proud of the success of the FSR-GSCA Volunteer Patient Leadership Training Conference," said Mary McGowan, Chief Executive Officer of FSR. "This training exemplifies our commitment to empowering individuals affected by sarcoidosis to become advocates for themselves and others. By fostering collaboration and knowledge sharing, we are driving progress towards improved outcomes and ultimately, a cure for this complex disease."

“As a rare disease, sarcoidosis is underfunded and under-resourced. The advocacy training received by the FSR volunteer leaders at this training will change the face of the disease. These volunteer leaders are the emissaries for progress,” said Dr. Daniel Culver, Chair of the Division of Pulmonary Medicine at Cleveland Clinic, a Founding Member of the FSR Global Sarcoidosis Clinic Alliance.

In addition to educational sessions, the conference provided a supportive environment for attendees to connect, share personal experiences, and forge lasting relationships with others who understand the challenges of living with sarcoidosis. These connections are invaluable in fostering a sense of community and resilience among those affected by the disease.

“To say it was an honor to be in everyone’s presence is an understatement! I can’t wait to help our cause,” said Andrea Maione, Volunteer Leader from Mount Sinai.

“Just from the one day I felt enriched and inspired by a number of people that I met,” said Susan Reyes, Volunteer Leader from Hospital for Special Surgery.

The success of the FSR-GSCA Volunteer Patient Leadership Training would not have been possible without the generous support of Cleveland Clinic. Their dedication and commitment to the sarcoidosis community are instrumental in advancing FSR’s mission to improve the lives of individuals impacted by sarcoidosis.

For more information about the Foundation for Sarcoidosis Research Global Sarcoidosis Clinic Alliance, visit www.stopsarcoidosis.org.

About the Foundation for Sarcoidosis Research:

The Foundation for Sarcoidosis Research (FSR) is the leading international nonprofit dedicated to finding a cure for sarcoidosis and improving care for sarcoidosis patients. Since its establishment in 2000, FSR has fostered over $6.5 million in sarcoidosis-specific research efforts.

Media contact: Cathi Davis, FSR Senior Manager of Marketing and Communications

Cathi@stopsarcoidosis.org

A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/af7fbf77-85e9-4cee-afb2-762f4f15dd2b


Primary Logo

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.


 

IntelligentValue Home
Close Window

DISCLAIMER

All content herein is issued solely for informational purposes and is not to be construed as an offer to sell or the solicitation of an offer to buy, nor should it be interpreted as a recommendation to buy, hold or sell (short or otherwise) any security.  All opinions, analyses, and information included herein are based on sources believed to be reliable, but no representation or warranty of any kind, expressed or implied, is made including but not limited to any representation or warranty concerning accuracy, completeness, correctness, timeliness or appropriateness. We undertake no obligation to update such opinions, analysis or information. You should independently verify all information contained on this website. Some information is based on analysis of past performance or hypothetical performance results, which have inherent limitations. We make no representation that any particular equity or strategy will or is likely to achieve profits or losses similar to those shown. Shareholders, employees, writers, contractors, and affiliates associated with ETFOptimize.com may have ownership positions in the securities that are mentioned. If you are not sure if ETFs, algorithmic investing, or a particular investment is right for you, you are urged to consult with a Registered Investment Advisor (RIA). Neither this website nor anyone associated with producing its content are Registered Investment Advisors, and no attempt is made herein to substitute for personalized, professional investment advice. Neither ETFOptimize.com, Global Alpha Investments, Inc., nor its employees, service providers, associates, or affiliates are responsible for any investment losses you may incur as a result of using the information provided herein. Remember that past investment returns may not be indicative of future returns.

Copyright © 1998-2017 ETFOptimize.com, a publication of Optimized Investments, Inc. All rights reserved.